A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A multi-centers, placebo-controlled, randomized, double-blinded, pilot clinical trial is
designed to evaluate the safety of the DA-3030 injection and to explore the efficacy for
Neuropathic pain.